In an exciting new project, Dr Kathryn Bowles (UK DRI at Edinburgh) will investigate the workings of a little-known gene which may play a role in the development of Parkinson’s. This work could deliver new targets for Parkinson’s treatments.
Previous research has found that people with higher levels of the LRRC37A2 gene are less likely to develop Parkinson's. The gene is thought to help protect the brain, and having less of it could be a risk factor for Parkinson’s.
Dr Bowles and her team will investigate what LRRC37A2 does and how having more of this gene in the brain could prevent people from developing Parkinson’s.